Written Comments for HHS, DOJ, and FTC’s RFI on Consolidation in Health Care Markets
June 5, 2024 — Economic Liberties submitted this comment in response to the Department of Justice (“DOJ”), Department of Health and Human Services (“HHS”), and Federal Trade Commission (“FTC”) joint request for information (“RFI”) regarding consolidation in health care markets.
Comment to the FTC and HHS on the Role of GPOs and Drug Wholesalers in America’s Drug Shortage Crisis
April 30, 2024 — Economic Liberties submitted the attached comment in response to the Federal Trade Commission and the Department of Health and Human Services’ joint request for information regarding the role of group purchasing organizations (GPOs) and drug wholesalers in America’s ongoing drug shortage crisis. The comment explains how GPOs contribute to shortages by pushing the price of generic drugs lower, imposing restricting and inflexible contract terms on medical providers, and undermine competition in pharmaceutical markets.
Medicare Advantage and Vertical Consolidation in Health Care
April 28, 2024 — This paper details the causes and costs of the new frontier of vertical healthcare consolidation and offers a
set of solutions to address it.
Why We Should Ban PBM Rebates
February 13, 2024 — This policy brief explains how pharmacy benefit managers weaponize rebates to raise prices for patients, debunks myths surrounding their purpose and use, and details how policymakers can eliminate them.
The Dirty Secret of Drug Shortages
October 19, 2023 — This brief explains the medical shortage problem and the multiple roles that GPOs play in medical supply markets. It then outlines a series of common-sense reforms to rein them in.